PALO ALTO, Calif., Jan. 19 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today the release of significant additions to its family of Pursuit(TM) LC (liquid chromatography) columns for pharmaceutical applications. New materials address needs from drug discovery to bioanalysis, saving time on analysis and method development. The Pursuit range now covers a much broader array of bioapplications, from cutting edge, ultra high pressure and fast gradient UHPLC to more traditional analytical and preparative HPLC techniques.
"These new columns expand the Varian LC family to provide either generic UHPLC discovery or tailored (U)HPLC method development solutions, designed to fit the needs of distinct parts of the pharmaceutical industry," says Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "We continue to provide life scientists with more high quality choices for addressing their specific application challenges."
For more technical information about Varian's HPLC instrumentation and consumables, please visit http://www.varianinc.com/products/
Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science, environmental, energy, and applied research and other applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc.'s common stock is traded on the NASDAQ Global Select Market under the symbol "VARI." Further information is available on the company's Web site at http://www.varianinc.com.
CONTACT: Public Relations of Varian, Inc., +1-925-942-4703,
Web site: http://www.varianinc.com/